Associate Consultant; Value, Pricing & Access

About You

Do you want to build your career at the forefront of strategic market access consulting, helping shape how innovative therapies reach patients?

Are you passionate about working on high-impact challenges in oncology, rare diseases and specialty care, where access strategy can truly change lives?

Do you enjoy solving complex problems at the intersection of science, value, pricing and payer decision-making?

Are you looking to join a high-growth, entrepreneurial consultancy where you can learn from experienced consultants and build a strong foundation in market access?

If so, consider a career at Prescient.

We're looking for an Associate Consultant to join our Value Price Access practice, built on the expertise of Dolon, now part of Prescient.

With the integration of Dolon, Prescient has launched a dedicated Value Price Access practice, combining deep technical expertise with strategic advisory capabilities.

Dolon brings a strong heritage in:

• Global pricing and access strategy
• Payer insights and HTA strategy
• Access strategy in complex and high-value therapeutic areas

Our work is particularly differentiated in oncology and rare diseases, where:

• Pricing and access decisions are highly scrutinised
• Evidence requirements are complex and evolving
• Strategic choices have significant patient and commercial implications

As part of Prescient, we now deliver fully integrated strategy across Commercial, Medical, Competitive Strategy and Access, helping clients maximise asset value across the entire product life cycle.

This is a unique opportunity to join a specialist, strategy-led access team within a broader, market-leading consultancy platform.

As an Associate Consultant, you will support the delivery of high-quality, insight-led strategy projects for global biopharma clients, developing your skills across research, analysis and strategic communication under the guidance of senior colleagues.

You will contribute to teams working on critical questions such as:

• How should a novel oncology asset be positioned for optimal reimbursement?
• What evidence is required to support value in rare diseases?
• How can pricing strategy be optimised across global markets?
• What are the payer risks and how can they be mitigated early?

Your time will be broadly split across:

• ~80% project delivery
• ~20% capability building, internal initiatives and professional development

You'll be part of a fast-growing, PE-backed organisation, where you will gain hands‑on exposure to client work, start to build your expertise in value, pricing and access strategy, and develop your career within a supportive and expert team.

• Support delivery of value, pricing and access strategy projects across the product life cycle, under the direction of senior team members
• Conduct literature searches and critically review, extract and summarise relevant evidence on pricing, reimbursement and payer decision-making
• Help translate research and evidence into clear insights, with guidance from senior colleagues
• Support landscape assessments, analogue research and policy analysis to inform client strategy
• Build up internal knowledge of pricing and reimbursement systems and market access policy trends worldwide
• Contribute to the preparation of client deliverables, reports and presentations
• Support logistical and planning tasks, including helping to coordinate stakeholder interviews and arrange meetings with external stakeholders
• Help manage own tasks and timelines to support delivery against client expectations
• Collaborate effectively with project teams across multiple work streams

• Support day-to-day communication with clients, as directed by senior team members
• Begin to build working relationships with client stakeholders
• Contribute to the delivery of high-quality, insight-driven outputs
• Participate in client meetings, workshops and presentations

• Support development of project proposals and pitch materials
• Contribute to internal knowledge sharing initiatives

• Work closely with colleagues…